Intervention

Human Insulin

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions6

Lead sponsors shown5

Clinical trials

5 shown

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueNCT02109029 · 2014-04-01

Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin ApplicationNCT01797601 · 2013-02-01

Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in ParaguayNCT02278913 · 2009-04-01

Primary Intervention With Mucosal InsulinNCT02620553 · 2007-09-01

Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor CellsNCT00523393 · 2007-08-01

Common conditions

Diabetes2 Diabetes Mellitus, Type 11 Hyperglycemia1 Obesity1 Type 1 Diabetes1 Type 2 Diabetes1

Leading sponsors

Eli Lilly and Company1 Heidelberg University1 Universidad Nacional de Asunción1 University Hospital Tuebingen1 University of Colorado, Denver1

Trial status mix

COMPLETED4

UNKNOWN1

Phase mix

PHASE12

PHASE42

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.